Walleye Capital LLC Vertex Pharmaceuticals Inc Transaction History

Walleye Capital LLC

$54.3 Billion
Q2 2024

A detailed history of Walleye Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Walleye Capital LLC holds 15,800 shares of VRTX stock, worth $7.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,800

Previous 31,000 49.03%

Holding current value

$7.94 Million

Previous $13 Million 42.85%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $21,211 - $26,218	-54 Reduced 1.9%	2,785 $1.31 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $3.84 Million - $4.2 Million	-9,416 Reduced 76.83%	2,839 $1.19 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $4.83 Million - $5.79 Million	-14,090 Reduced 53.48%	12,255 $4.99 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $8.91 Million - $9.55 Million	26,345 New	26,345 $9.16 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $13.2 Million - $15 Million	-46,509 Reduced 83.29%	9,328 $2.94 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $3.2 Million - $3.6 Million	-11,186 Reduced 16.69%	55,837 $16.1 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $10.3 Million - $11.5 Million	37,649 Added 128.17%	67,023 $19.4 Million
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $3.91 Million - $4.87 Million	16,634 Added 130.57%	29,374 $8.28 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $4.09 Million - $4.82 Million	-18,463 Reduced 59.17%	12,740 $3.33 Million
Q4 2021 Mar 03, 2022	BUY	$177.01 - $223.45 $420,044 - $530,246	2,373 Added 8.23%	31,203 $6.85 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $471,795 - $527,976	-2,601 Reduced 8.28%	28,830 $5.23 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $5.62 Million - $6.62 Million	29,963 Added 2041.08%	31,431 $6.34 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $303,905 - $354,243	1,468 New	1,468 $315,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $709,630 - $946,436	-3,428 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $876,368 - $1.04 Million	3,428 New	3,428 $933,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $860,882 - $1.13 Million	-3,818 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $319,232 - $396,000	1,598 Added 71.98%	3,818 $908,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $291,742 - $391,842	1,750 Added 372.34%	2,220 $486,000
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $31,583 - $35,547	190 Added 67.86%	470 $80,000
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $18,107 - $20,940	-110 Reduced 28.21%	280 $51,000
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $63,854 - $75,933	390 New	390 $72,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Vertex Pharmaceuticals Inc Transaction History